Cwm, LLC Equillium, Inc. Transaction History

Cwm, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Sep 15, 2021	BUY	$5.03 - $10.5 $1,509 - $3,150	300 New	300 $2,000
Q1 2021 Apr 27, 2021	SELL	$5.03 - $10.5 $1,509 - $3,150	-300 Closed	0 $0
Q4 2020 Sep 15, 2021	BUY	$3.48 - $6.58 $1,044 - $1,974	300 New	300 $2,000
Q4 2020 Jan 27, 2021	SELL	$3.48 - $6.58 $1,044 - $1,974	-300 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$2.78 - $26.5 $833 - $7,950	300 New	300 $2,000
Q3 2020 Oct 19, 2020	SELL	$2.78 - $26.5 $833 - $7,950	-300 Closed	0 $0
Q2 2020 Sep 15, 2021	SELL	$2.34 - $3.53 $1,638 - $2,471	-700 Reduced 70.0%	300 $2,000
Q2 2020 Jul 22, 2020	BUY	$2.34 - $3.53 $1,638 - $2,471	700 Added 233.33%	1,000 $3,000
Q1 2020 Sep 15, 2021	SELL	$2.3 - $5.5 $1,609 - $3,850	-700 Reduced 70.0%	300 $2,000
Q1 2020 Apr 28, 2020	BUY	$2.3 - $5.5 $1,609 - $3,850	700 Added 233.33%	1,000 $3,000
Q4 2019 Sep 14, 2021	BUY	$3.0 - $5.0 $900 - $1,500	300 New	300 $2,000
Q4 2019 Jan 27, 2020	SELL	$3.0 - $5.0 $900 - $1,500	-300 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$3.31 - $5.6 $993 - $1,680	300 New	300 $2,000
Q3 2019 Oct 22, 2019	SELL	$3.31 - $5.6 $993 - $1,680	-300 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$5.28 - $8.2 $1,584 - $2,460	300 New	300 $2,000
Q2 2019 Jul 31, 2019	SELL	$5.28 - $8.2 $1,584 - $2,460	-300 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$5.84 - $12.02 $1,752 - $3,606	300 New	300 $0

11.3M

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $23.7M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.